Clinical trial
Aerosol L9-NC and Temozolomide in Ewing's Sarcoma
NCT00492141 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00492141 |
|---|---|
| Title | Aerosol L9-NC and Temozolomide in Ewing's Sarcoma |
| Official title | Aerosol Liposomal 9-Nitro-20(S)-Camptothecin (L9-NC) and Temozolomide in Ewing's Sarcoma and Other Solid Tumors With Lung Involvement |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Ewing's Sarcoma |
| Intervention type | Drug |
| Interventions | Temozolomide, L9-NC |
| Enrollment | 10 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | Sep 1, 2009 |
| First posted | Jun 27, 2007 |
| Last update posted | Aug 2, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: